Thread: Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form o
View Single Post
Old 02-13-2017, 11:42 AM
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,318
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,318
15 yr Member
Exclamation
Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS)

Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS) Nasdaq:VYGR


Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS)
Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS) | P&T Community


ALS Latest 2017: How Lou Gehrig's Disease Progression Could Be Delayed

ALS Latest 217: How Lou Gehrig's Disease Progression Could Be Delayed
Last edited by MuonOne; 02-13-2017 at 06:54 PM.
MuonOne is offline   Reply With QuoteReply With Quote